SCOLR Pharma (DDD) Won't Make Previous FY10 Rev Guidance, Cites Nutritional Product Sales
Tweet Send to a Friend
SCOLR Pharma, Inc. (AMEX: DDD) today announced that it will be unable to meet its previously-issued 2010 revenue expectations with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
